Article info
Inflammatory bowel disease
Original article
ClC-3 chloride channel/antiporter defect contributes to inflammatory bowel disease in humans and mice
- Correspondence to Professor Jia-Guo Zhou, Department of Pharmacology, Zhongshan School of Medcine, Sun Yat-Sen University, 74 Zhongshan 2 Rd, Guangzhou, Guangdong 510080, China; zhoujg{at}mail.sysu.edu.cn and Rui-Ping Pang, Department of Physiology, Zhongshan School of Medicine, Sun Yat-Sen University, 74 Zhongshan 2 Rd, Guangzhou, Guangdong, 510080,China; pangruip{at}mail.sysu.edu.cn
Citation
ClC-3 chloride channel/antiporter defect contributes to inflammatory bowel disease in humans and mice
Publication history
- Received May 1, 2013
- Revised December 22, 2013
- Accepted December 23, 2013
- First published January 17, 2014.
Online issue publication
October 26, 2017
Article Versions
- Previous version (26 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions